Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
keyhole limpet hemocyanin (KLH)
BIOLOGICAL
3 trials
Sponsors
Biogen
, NYU Langone Health
, Tonix Pharmaceuticals, Inc.
Conditions
Glioblastoma
Glioma
Multiple Sclerosis
Phase 1 First-in-human Study Involving Healthy Subjects
Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects
Completed
NCT07473752
Tonix Pharmaceuticals, Inc.
Phase 1 First-in-human Study Involving Healthy Subjects
Start: 2023-07-18
End: 2024-02-22
Updated: 2026-03-16
Phase 2
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
Withdrawn
NCT02754362
NYU Langone Health
Glioblastoma, Glioma
Start: 2016-11-30
End: 2019-06-30
Updated: 2020-01-13
Phase 4
The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis
Completed
NCT00536120
Biogen
Multiple Sclerosis
Start: 2008-01-31
End: 2009-12-31
Updated: 2017-02-15